Bloomberg North August 22 2017 Part2
Frequency Therapeutics is developing a drug that stimulates dormant cells in the ear. In effect, the treatment "re-grows" the ability to hear. Globalive chairman Anthony Lacavera talks to CEO and co-founder David Lucchino. Qloo uses an algorithm to examine public information for patterns in consumer sentiment, in an effort to keep on top of changing pop culture tastes. Anthony Lacavera talks to Qloo’s founder Alex Elias about cultural AI.